84 related articles for article (PubMed ID: 9648281)
1. The newly synthetized pyridobenzoxazocynone inhibits HIV-1 reverse transcriptase activity.
Nowak D; Glinka R; Pietras T; Cieslinski M; Mazerant P; Idowski P; Leder M; Sidorkiewicz M
Farmaco; 1997 Dec; 52(12):751-3. PubMed ID: 9648281
[TBL] [Abstract][Full Text] [Related]
2. Thiourea-based non-nucleoside inhibitors of HIV reverse transcriptase as bifunctional organocatalysts in the asymmetric Strecker synthesis.
Tsogoeva SB; Hateley MJ; Yalalov DA; Meindl K; Weckbecker C; Huthmacher K
Bioorg Med Chem; 2005 Oct; 13(19):5680-5. PubMed ID: 15964195
[TBL] [Abstract][Full Text] [Related]
3. Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors.
Bode ML; Gravestock D; Moleele SS; van der Westhuyzen CW; Pelly SC; Steenkamp PA; Hoppe HC; Khan T; Nkabinde LA
Bioorg Med Chem; 2011 Jul; 19(14):4227-37. PubMed ID: 21700466
[TBL] [Abstract][Full Text] [Related]
4. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
5. Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Ruiz-Caro J; Basavapathruni A; Kim JT; Bailey CM; Wang L; Anderson KS; Hamilton AD; Jorgensen WL
Bioorg Med Chem Lett; 2006 Feb; 16(3):668-71. PubMed ID: 16298131
[TBL] [Abstract][Full Text] [Related]
6. Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Spallarossa A; Cesarini S; Ranise A; Schenone S; Bruno O; Borassi A; La Colla P; Pezzullo M; Sanna G; Collu G; Secci B; Loddo R
Eur J Med Chem; 2009 May; 44(5):2190-201. PubMed ID: 19058881
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
Tucker TJ; Sisko JT; Tynebor RM; Williams TM; Felock PJ; Flynn JA; Lai MT; Liang Y; McGaughey G; Liu M; Miller M; Moyer G; Munshi V; Perlow-Poehnelt R; Prasad S; Reid JC; Sanchez R; Torrent M; Vacca JP; Wan BL; Yan Y
J Med Chem; 2008 Oct; 51(20):6503-11. PubMed ID: 18826204
[TBL] [Abstract][Full Text] [Related]
8. Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymes.
Klunder JM; Hoermann M; Cywin CL; David E; Brickwood JR; Schwartz R; Barringer KJ; Pauletti D; Shih CK; Erickson DA; Sorge CL; Joseph DP; Hattox SE; Adams J; Grob PM
J Med Chem; 1998 Jul; 41(16):2960-71. PubMed ID: 9685235
[TBL] [Abstract][Full Text] [Related]
9. Search for new non-nucleoside inhibitors of HIV-1 reverse transcriptase (HIV-1 RT).
Brzezińska E; Glinka R
Acta Pol Pharm; 2002; 59(5):379-86. PubMed ID: 12602800
[TBL] [Abstract][Full Text] [Related]
10. Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Sweeney ZK; Dunn JP; Li Y; Heilek G; Dunten P; Elworthy TR; Han X; Harris SF; Hirschfeld DR; Hogg JH; Huber W; Kaiser AC; Kertesz DJ; Kim W; Mirzadegan T; Roepel MG; Saito YD; Silva TM; Swallow S; Tracy JL; Villasenor A; Vora H; Zhou AS; Klumpp K
Bioorg Med Chem Lett; 2008 Aug; 18(15):4352-4. PubMed ID: 18632268
[TBL] [Abstract][Full Text] [Related]
11. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
Lavecchia A; Costi R; Artico M; Miele G; Novellino E; Bergamini A; Crespan E; Maga G; Di Santo R
ChemMedChem; 2006 Dec; 1(12):1379-90. PubMed ID: 17089434
[TBL] [Abstract][Full Text] [Related]
12. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).
Di Santo R; Costi R; Artico M; Miele G; Lavecchia A; Novellino E; Bergamini A; Cancio R; Maga G
ChemMedChem; 2006 Dec; 1(12):1367-78. PubMed ID: 17089433
[TBL] [Abstract][Full Text] [Related]
13. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
[TBL] [Abstract][Full Text] [Related]
14. Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
Medina-Franco JL; Martínez-Mayorga K; Juárez-Gordiano C; Castillo R
ChemMedChem; 2007 Aug; 2(8):1141-7. PubMed ID: 17477343
[No Abstract] [Full Text] [Related]
15. Structure-based design, synthesis, and in vitro assay of novel nucleoside analog inhibitors against HIV-1 reverse transcriptase.
Liu X; Xie W; Huang RH
Bioorg Med Chem Lett; 2005 Aug; 15(16):3775-7. PubMed ID: 15993595
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of N-acetyl-beta-aryl-1,2-didehydroethylamines as new HIV-1 RT inhibitors in vitro.
Cheng P; Jiang ZY; Wang RR; Zhang XM; Wang Q; Zheng YT; Zhou J; Chen JJ
Bioorg Med Chem Lett; 2007 Aug; 17(16):4476-80. PubMed ID: 17574419
[TBL] [Abstract][Full Text] [Related]
17. [d4U]-butyne-[HI-236] as a non-cleavable, bifunctional NRTI/NNRTI HIV-1 reverse-transcriptase inhibitor.
Hunter R; Muhanji CI; Hale I; Bailey CM; Basavapathruni A; Anderson KS
Bioorg Med Chem Lett; 2007 May; 17(9):2614-7. PubMed ID: 17317163
[TBL] [Abstract][Full Text] [Related]
18. Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
O'Meara JA; Jakalian A; LaPlante S; Bonneau PR; Coulombe R; Faucher AM; Guse I; Landry S; Racine J; Simoneau B; Thavonekham B; Yoakim C
Bioorg Med Chem Lett; 2007 Jun; 17(12):3362-6. PubMed ID: 17451954
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors.
Xu B; Sun Y; Guo Y; Cao Y; Yu T
Bioorg Med Chem; 2009 Apr; 17(7):2767-74. PubMed ID: 19269831
[TBL] [Abstract][Full Text] [Related]
20. Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.
Li Z; Han J; Chen HF
Chem Biol Drug Des; 2008 Nov; 72(5):350-9. PubMed ID: 19012571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
